Parallax Volatility Advisers
XLRN

Parallax Volatility Advisers’s Acceleron Pharma XLRN Stock Holding History

Parallax Volatility Advisers’s Portfolio XLRN Stock Details XLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-102,614
Closed -$17.7M – 3667
2021
Q3 		$17.7M Buy
+102,614
New +$13.4M 0.01% 711
2020
Q4 		– Sell
-11,391
Closed -$1.28M – 3626
2020
Q3 		$1.28M Buy
+11,391
New +$1.13M ﹤0.01% 1889
2018
Q3 		– Sell
-15,348
Closed -$754K – 3890
2018
Q2 		$745K Buy
+15,348
New +$559K ﹤0.01% 1172
2018
Q1 		– Sell
-5,712
Closed -$242K – 4823
2017
Q4 		$242K Buy
5,712
+504
+10% +$18.9K ﹤0.01% 2122
2017
Q3 		$194K Buy
5,208
+536
+11% +$18.6K ﹤0.01% 1477
2017
Q2 		$142K Buy
+4,672
New +$135K ﹤0.01% 1559

Parallax Volatility Advisers's XLRN Position: Q4 2021 in Review

Parallax Volatility Advisers sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 102,614 shares — an estimated $17.7M sold.

Parallax Volatility Advisers first reported a position in XLRN in Q2 2017 and held it in 6 quarters. The position peaked at $17.7M in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

  • Parallax Volatility Advisers reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
  • Parallax Volatility Advisers sold 102,614 Acceleron Pharma shares in Q4 2021, an estimated $17.7M.
  • Parallax Volatility Advisers first reported a position in Acceleron Pharma in Q2 2017 and held it in 6 quarters.
  • Parallax Volatility Advisers's Acceleron Pharma position peaked at $17.7M in Q3 2021.
  • 1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on Parallax Volatility Advisers's 13F filing for Q4 2021, filed 14 Feb 2022.